Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001181431-13-022851

Chief Executive Officer acquired 2,846,715 shares (other)

From the SEC's structured data for this filing

Trades in this filing

FREER RICHARD J · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2013-04-12 Other acquisition : show line 1 in the form +2,846,715 $0.05 $130,095 7,485,141 D
Loading xslF345X03/rrd377127.xml…